Search Results - "Al ayoub, Yuosef"
-
1
Development and evaluation of nanoemulsion and microsuspension formulations of curcuminoids for lung delivery with a novel approach to understanding the aerosol performance of nanoparticles
Published in International journal of pharmaceutics (25-02-2019)“…[Display omitted] Extensive research has demonstrated the potential effectiveness of curcumin against various diseases, including asthma and cancers. However,…”
Get full text
Journal Article -
2
Calculating the surface energies of crystals on a face-specific and whole particle basis: Case study of the α- and β-polymorphic forms of L-glutamic acid
Published in Powder technology (01-12-2024)“…Molecular-scale modelling for predicting surface energies on a face-specific and whole particle basis is applied to all the crystallographically-independent…”
Get full text
Journal Article -
3
Inhaled dry powder liposomal azithromycin for treatment of chronic lower respiratory tract infection
Published in International journal of pharmaceutics (25-03-2024)“…[Display omitted] A dry powder inhaled liposomal azithromycin formulation was developed for the treatment of chronic respiratory diseases such as cystic…”
Get full text
Journal Article -
4
In-Vitro In-Vivo Correlation (IVIVC) of Inhaled Products Using Twin Stage Impinger
Published in Journal of pharmaceutical sciences (01-02-2022)“…In vitro dissolution testing as a form of quality control has become a necessity in the pharmaceutical industry. As such, the need to establish a method that…”
Get more information
Journal Article -
5
Ex vivo and in vitro evaluation of the influence of the inhaler device and formulation on lung deposition of budesonide
Published in Powder technology (15-07-2020)“…Two different types of dry powder inhalers (Easyhaler® and RS01®) were used in this work to evaluate the ex vivo and in vitro performance of a budesonide…”
Get full text
Journal Article -
6
Inhaleddry powder liposomal azithromycin for treatment of chronic lower respiratory tract infection
Published in International journal of pharmaceutics (22-01-2024)“…A dry powder inhaled liposomal azithromycin formulation was developed for the treatment of chronic respiratory diseases such as cystic fibrosis and…”
Get full text
Journal Article -
7
Development of a dry powder inhaler and nebulised nanoparticle-based formulations of curcuminoids for the potential treatment of lung cancer : development of drug delivery formulations of curcuminoids to the lungs using air jet milling and sonocrystallisation techniques for dry powder inhaler preparations, and nanoemulsion and microsuspension for nebuliser formulations
Published 01-01-2017Get full text
Dissertation